Teva Announces Presentation Of New Data On Multiple Sclerosis And Parkinson's Disease Treatments At 2011 American Academy Of Neurology Annual Meeting
Links shared publicly online about this topic.
- 370total visits
Teva Announces Presentation Of New Data On Multiple Sclerosis And Parkinson's Disease Treatments At 2011 American Academy Of Neurology Annual Meeting
View full resource at medicalnewstoday.com
Tags: Neurology, Multiple Sclerosis, Parkinson's Disease, Disease and Condition, Pharma, Teva Pharmaceutical Industries, disease
Most Recently Shared on April 12, 2011 at 2:34 pm By:
Teva Announces Presentation Of New Data On Multiple Sclerosis And Parkinson's Disease Treatments At 2011 America... http://bit.ly/gv7e1T
Teva Announces Presentation Of New Data On Multiple Sclerosis And Parkinson's Disease Treatments At 2011 American Academy Of Neurology Annual Meeting
medicalnewstoday.com — “Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced that several new studies further support the efficacy and safety of the company's innovative central nervous system (CNS) product” View full resource at medicalnewstoday.com
Most Recently Shared on April 12, 2011 at 12:05 pm By:
Teva Announces Presentation Of New Data On Multiple Sclerosis And Parkinson's Disease Treatments At 2011 American Acad... http://mnt.to/3TwQ
Teva Announces Presentation of New Data on Multiple Sclerosis and Parkinson's Disease Treatments at 2011 American Academy of Neurology Annual Meeting - Drugs.com MedNews
drugs.com — “Data from Phase III Trial of Oral Laquinimod for Multiple Sclerosis to be Presented as Late-Breaking News Apr 11, 2011 - Teva Pharmaceutical Industries Ltd. (NA” View full resource at drugs.com
Most Recently Shared on April 11, 2011 at 1:10 pm By:
Teva Announces Presentation of New Data on Multiple Sclerosis and Parkinson's Disease Treatments at 2011 A... http://bit.ly/gyYJt8 #drug
Advertisement

